In addition, a study undertaken by Karikoski et al. showed significantly fewer Tregs in murine tumour models when stabilin-1−/− mice were compared to wild type controls and also demonstrated smaller primary and metastatic tumours in stabilin-1−/− mice, compared to wild type mice [48]. This evidence concerns the gene STAB1 and neoplasm.